The Intelligence Hub
One independent view of the European theranostics landscape — trials, targets, sponsors and the centres that can actually deliver therapy. Filter it, score it, save it, export it.
Everything in one workspace
Each capability stands alone or works together. Screens below are illustrative.
Map every RLT trial in Europe
See radioligand-therapy and RIV trials mapped by molecular target, isotope, phase, sponsor, country and status — sourced from ClinicalTrials.gov and CTIS and refreshed continuously.
- Filter by PSMA, SSTR2, FAP, GRPR and more
- Isotope view: Lu-177, Ac-225, Y-90, Ra-223, I-131
- Phase, sponsor, country and recruitment status
Know which centres can actually treat
Our signature layer: a readiness score for European centres based on theranostics activity and capability — the ground-truth that global trial databases don't capture.
- Score & rank centres by readiness and activity
- Public vs private, isotope capability, country
- Built on the Nucleascope centre directory
Track who's developing what
See the pipeline by target and sponsor and how it shifts over time — a competitive-landscape view by geography to spot moves and white-space early.
- Sponsor activity by target and country
- Pipeline maturity and momentum over time
- Exportable competitive snapshots
Engage the people, see the gaps
Identify active contributors, case authors and congress activity (aggregated and anonymised), and read workforce and capacity signals from live staffing demand by region and profession.
- KOL & engagement signals, compliant by design
- Workforce / locum demand by region & profession
- Direct, multilingual reach via the community
Filters, saved views, export & API
Filter by target, country, phase and sponsor; save views for your team; export to PDF. Enterprise adds a data feed / API and a named analyst.
See the Hub on your target and markets
A 30-minute walkthrough, tailored to you.
Book an intelligence walkthrough